Professional Documents
Culture Documents
COLing the Shots is a monthly publication by COL which provides insights on investment
opportunities based on global and local developments that could affect the market. COLing the Shots
aims to provide timely and relevant information and analysis as well as a model portfolio for
successful investing.
Key Highlights
The market is down by 2.7% from its end April level driven by numerous factors including the
disappointing first quarter earnings season and the worse than expected first quarter GDP
numbers. Aside from the said factors, technical indicators point to a threat that interest rates
would continue to climb in the near term.
Despite all the bad news, I would like to reiterate our view that we should stay bullish over the
long term and take advantage of the ongoing correction to increase our exposure in the stock
market. Although the recently concluded earnings season was quite disappointing, median
earnings growth remained healthy at 12.5%. Moreover, earnings were not weak across the
board. As such, we should just be selective and focus on companies that were sold off despite
delivering in line or better than expected earnings results.
The below expected first quarter GDP growth numbers were not entirely negative. Consumer
spending and capital formation remained strong during the first quarter. Manufacturing also
continued to grow and so did the services sector.
We also do not believe that a steep rise in interest rates can be sustained given the numerous
challenges facing the global economy at present.
We are removing GTCAP and DNL from our COLing the Shots stock picks list. We believe
that we should take the opportunity to lock in gains as the valuations of both stocks are no
longer attractive. Meanwhile, we are adding FLI and URC to our list of stock picks.
We like FLI given its successful entry into the mid-rise and high rise residential buildings
space catering to the mid-income market and its growing rental income portfolio. In fact, rental
revenues are projected to grow rapidly by a CAGR of 19.3% from 2014 to 2020 as FLI plans
to almost triple its gross leaseable area in five years. Valuations are also attractive, with FLI
trading at only 8.7X 2015E P/E and 46.5% below its NAV. We recommend accumulating FLI
at prices below Php1.94/sh.
URC has successfully grown its branded consumer foods business both locally and
internationally allowing profits to increase by a CAGR of 22.4% during the past five years.
However, the stock has been sold down by 14.1% from its end April level despite the company
reporting in line first quarter earnings results. In our opinion, the ongoing sell-off is an
opportunity to buy the stock at a cheaper valuation as nothing is fundamentally wrong with the
company. We advise investors to accumulate URC at prices below Php184.00/sh.
Head of Research
April Lynn Tan, CFA
Analysts
George Ching
Richard Laeda, CFA
Charles William Ang, CFA
Jed Frederick Pilarca
Garie Ouano
Meredith Hazel Cua
Angelo Lecaros
Michelle Yu
Above
Inline
Below
MBT
BDO
CHIB
RCB
BPI
PNB
SECB
EW
UBP
CEB
ABS
AT
ICT
GMA7
EEI
PX
MWC
IMI
FPH
NIKL
AEV
JGS
SCC
AGI
GLO
AC
COSCO
EDC
GTCAP
DMC
FGEN
MPI
CIC
SM
DNL
PIP
EMP
SSI
JFC
URC
PGOLD
CNPF
RFM
RWM
RRHI
TEL
BEL
AP
BLOOM
ALI
MCP
FLI
MER
RLC
CPG
VLL
MEG
SMPH
Total
Percentage
11
24
23
19.00%
41.40%
39.70%
Meanwhile, just this week, the government announced that first quarter GDP grew 5.2%, slower than
consensus growth forecast of 6.6%. The major disappointment came from public construction which
fell by 24.6% during the first quarter after growing by 5.1% during 4Q14. Consequently, government
spending increased by only 4.8% during the first quarter of 2015, down from 9.8% during the fourth
quarter of 2014.
FRIDAY, 29 MAY 2015
page 2
Aside from the said factors, I would like to share with you what COLs chairman Mr. Edward Lee told
me earlier this month when I asked him whether or not we made a mistake by being cautious.
Although the PSEi rebounded a few weeks earlier, Mr. Lee said he believed that we should remain
cautious because of the increase in the 10-year bond rates. He also said that technical indicators
point to a threat that interest rates would rise more sharply in the near term.
Note that the U.S. 10-year bond rate is currently at 2.1%, up from a low of 1.65% early this 2015.
The Philippine 10-year bond rate is also higher at 4.3% from a low of 3.1% early this year. In the
past, bond rates typically go down when equity markets drop as investors shift from stocks to bond in
search of safe havens. Circumstances today are quite unusual as bond rates are rising despite the
lackluster performance of the stock market.
Exhibit 2: US 10-Year Bond Rates
3.0
2.5
2.0
1.5
1.0
5.0
4.5
4.0
3.5
3.0
2.5
2.0
page 3
If both stocks and bonds are being sold down, where are funds flowing to? Personally, I cant find
a convincing argument as to why interest rates can go up significantly. In our COLing the Shots
report two months ago, we already shared our view that even if the Fed does raise interest rates
this June, the increase is not expected to be significant as implied by the changing assessment of
the appropriate pace of policy firming by Fed meeting participants and the numerous threats facing
the global economy. Nevertheless, given the threat that interest rates would continue to rise in the
short term, there is room to be more cautious in stock investing. After all, higher rates make bonds
more attractive relative to stocks. Higher rates also negatively affect the valuations of stocks as the
required rate of return increases.
Despite all the bad news, I would like to reiterate our view that we should stay bullish over the long
term and take advantage of the ongoing correction to increase our exposure in the stock market at
more attractive levels.
Although the recently concluded earnings season was quite disappointing, median earnings growth
remained healthy at 12.5% during the first quarter. Moreover, earnings were not weak across the
board. As such, there is no need to avoid stocks altogether. We should just be selective and focus
on companies that were sold off despite delivering in line or better than expected earnings results.
Moreover, despite the below expected first quarter GDP growth numbers, the results were not
entirely negative. Consumer spending and capital formation remained strong during the first quarter.
Consumer spending was up by 5.4%, in line with its historical average growth. Capital formation
climbed 11.8% brought about by the significant increase in private sector construction (+14.2%) and
the 14.3% jump in investments in durable equipment. Manufacturing also continued to grow as it
was up by 5.9% during the first quarter. Services were likewise strong, rising by 5.6% during the
same period.
The strong growth in capital formation should bode well for economic growth over the long term as it
signifies an increase in productive capacity while the continuous improvement in the manufacturing
and services sector should help create more jobs locally.
Finally, as discussed earlier, I do not believe that a steep rise in interest rates can be sustained. As
a result, any stock market sell-off resulting from an interest rate hike scare should be viewed as an
opportunity to buy stocks.
Removing GTCAP and DNL from our COLing the Shots Stock Picks
This month, we are removing GTCAP and DNL from our COLing the Shots stock picks list.
Note that despite the markets correction, GTCAPs share price still continued to increase this May,
rising by 8.8% since we last came out with our COLing the Shots report. The increase was brought
about by several factors including its strong first quarter earnings results and the stocks inclusion in
the MSCI index. However, we believe that GTCAP is already fairly valued as it is trading almost at
par with our FV estimate of Php1,470. Since we first recommended GTCAP this January, the stock
is up by 22.6%. As such, we recommend locking in gains and to just wait for pullbacks to buy back
the stock.
page 4
We are also removing DNL from our stock picks list. Although we still like DNL fundamentally,
valuations are no longer attractive (in fact, the stock has been trading above our fair value estimate
for quite some time now). With the market undergoing a significant correction, we believe that it
would be a good time to lock in gains as the stocks elevated price makes it vulnerable to a sharp
sell-off. Since we first recommended DNL in February 2013, the stock has appreciated by 217.3%.
As far as our remaining stock picks are concerned, there are no new developments prompting us to
change our positive view. In fact, out of the five remaining stocks in our COLing the Shots list, three
reported better than expected first quarter earnings results, namely MBT, CEB and FGEN. AC and
SMPH reported in-line earnings results.
FGEN was battered significantly last month (down 7.5% for the month to date period) despite
announcing better than expected earnings results. Investors seem to be too fixated with FGENs poor
earnings growth outlook for this year (down 4%). However, they fail to take into consideration that
profits would grow by 30% next year. Consequently, we believe that the steep sell-off is unwarranted.
At FGENs current price of Php26.00, capital appreciation potential is significant at 38.5%.
page 5
Lastly, I would like to reiterate what we said in last months report. Although the ongoing correction is
an excellent opportunity to buy stocks at more attractive valuations, nobody knows where the bottom
will be or when the correction will finish. Therefore, peso cost averaging is preferred over lump sum
investing, especially when prices hit attractive levels.
Exhibit 4: COLing the Shots Stock Picks
Price
15 FV
AC
780
877
8/5/2013
600
30.00%
701.6
MBT
90
109
1/23/2014
79.8
12.80%
87.2
SMPH
18.78
23.6
1/23/2014
14.48
29.70%
18.88
FGEN
26
36
1/20/2014
26
0.00%
28.8
CEB
87.85
156
1/20/2014
86.5
1.60%
124.8
FLI
1.85
2.42
5/28/2014
1.85
0.00%
1.94
URC
187
230
184
page 6
BUY
HOLD
SELL
Important Disclaimers
Securities recommended, offered or sold by COL Financial Group, Inc.are subject to investment risks, including the possible loss of the principal amount
invested. Although information has been obtained from and is based upon sources we believe to be reliable, we do not guarantee its accuracy and it may
be incomplete or condensed. All opinions and estimates constitute the judgment of COLs Equity Research Department as of the date of the report and are
subject to change without notice. This report is for informational purposes only and is not intended as an offer or solicitation for the purchase or sale of a
security. COL Financial ans/or its employees not involved in the preparation of this report may have investments in securities or derivatives of securities of
securities of the companies mentioned in this report, and may trade them in ways different from those discussed in this report.
2401-B East Tower, Philippine Stock Exchange Centre, Exchange Road, Ortigas Center, Pasig City, 1605 Philippines
Tel: +632 636-5411
Website: http://www.colfinancial.com
page 7